Xiaohang Cao Selected Research

Oxamniquine

10/2018	Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents.
1/2017	Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy.
1/2016	Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohang Cao Research Topics

Disease

5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2010 - 12/2005
4	Schistosomiasis (Bilharziasis) 01/2020 - 01/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2010 - 12/2005
2	Infections 01/2020 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 10/2018 - 01/2016
1	Hypoxia (Hypoxemia) 01/2012
1	Cholera 08/2011
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2007

Drug/Important Bio-Agent (IBA)

6	CopperIBA 01/2012 - 12/2005
4	ZincIBA 07/2010 - 12/2005
4	Superoxide DismutaseIBA 07/2010 - 12/2005
3	Oxamniquine FDA Link 10/2018 - 01/2016
2	Praziquantel (Biltricide)FDA Link 01/2020 - 10/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2020
1	HycanthoneIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2012
1	Oxygen (Dioxygen)IBA 01/2012
1	EnzymesIBA 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2011
1	MetalsIBA 06/2008
1	DisulfidesIBA 06/2008
1	LigandsIBA 01/2007
1	Superoxide Dismutase-1IBA 01/2007
1	Superoxides (Superoxide)IBA 12/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2018
1	Therapeutics 01/2017